Fusion Pharmaceuticals Inc. Interest Expense, Other
Fusion Pharmaceuticals Inc. reported Interest Expense, Other of $1.85 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-07.
Discontinued › Expense Statement
us-gaap:InterestExpenseOther · last filed 2024-05-07
- Fusion Pharmaceuticals Inc. interest expense, other for the quarter ending 2024-03-31 was $1.85M, a 51.43% increase year-over-year.
- Fusion Pharmaceuticals Inc. interest expense, other for the quarter ending 2023-12-31 was $1.34M, a 14.38% increase year-over-year.
- Fusion Pharmaceuticals Inc. interest expense, other for the quarter ending 2023-09-30 was $1.32M, a 246.86% increase year-over-year.
- Fusion Pharmaceuticals Inc. interest expense, other for the quarter ending 2023-06-30 was $1.28M, a 410.76% increase year-over-year.
- Fusion Pharmaceuticals Inc. interest expense, other for fiscal 2023 was $5.17M, a 186.84% increase from fiscal 2022.
- Fusion Pharmaceuticals Inc. interest expense, other for fiscal 2022 was $1.80M.
| Period end | Interest Expense, Other 3 month | Interest Expense, Other 6 month | Interest Expense, Other 9 month | Interest Expense, Other 12 month |
|---|---|---|---|---|
| 2024-03-31 | $1.85M 10-Q · filed 2024-05-07 | $3.19M derived: sum of 2 quarters · filed 2024-05-07 | $4.51M derived: sum of 3 quarters · filed 2024-05-07 | $5.79M derived: sum of 4 quarters · filed 2024-05-07 |
| 2023-12-31 | $1.34M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | $2.66M derived: sum of 2 quarters · filed 2024-03-20 | $3.94M derived: sum of 3 quarters · filed 2024-03-20 | $5.17M 10-K · filed 2024-03-20 |
| 2023-09-30 | $1.32M 10-Q · filed 2023-11-07 | $2.61M derived: sum of 2 quarters · filed 2023-11-07 | $3.83M 10-Q · filed 2023-11-07 | $5.00M derived: sum of 4 quarters · filed 2024-05-07 |
| 2023-06-30 | $1.28M 10-Q · filed 2023-08-08 | $2.50M 10-Q · filed 2023-08-08 | $3.67M derived: sum of 3 quarters · filed 2024-05-07 | $4.05M derived: sum of 4 quarters · filed 2024-05-07 |
| 2023-03-31 | $1.22M 10-Q · filed 2024-05-07 | $2.39M derived: sum of 2 quarters · filed 2024-05-07 | $2.77M derived: sum of 3 quarters · filed 2024-05-07 | $3.02M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | $1.55M derived: sum of 2 quarters · filed 2024-03-20 | $1.80M derived: sum of 3 quarters · filed 2024-03-20 | $1.80M 10-K · filed 2024-03-20 |
| 2022-09-30 | $382.00K 10-Q · filed 2023-11-07 | $633.00K derived: sum of 2 quarters · filed 2023-11-07 | $633.00K 10-Q · filed 2023-11-07 | |
| 2022-06-30 | $251.00K 10-Q · filed 2023-08-08 | $251.00K 10-Q · filed 2023-08-08 |